The Speakers

The speakers at this year’s Clinical Trials in Oncology will include:

Chair Day One:
Ivan Dikic
MD, PhD, Professor of Biochemistry, Institute of Biochemistry II Goethe University Medical School Frankfurt
Chair Day Two: Christof von Kalle MD, Director National Center for Tumour Diseases (NCT) Heidelberg
  Head, Department Translational Oncology German Cancer Research Center (DKFZ)
Mia de Smet PhD, Clinical Resource and Development Director, Oncology Business Unit Novartis
Philip S. Murphy PhD, Director, Oncology Medicines Development Center GlaxoSmithKline
Stefano Persiani PhD, Director Translational Sciences and Pharmacokinetics Department Rottapharm-Madaus
Patrick Squiban MD, Chief Medical Officer, EVP Medical and Regulatory Affairs Innate Pharma
Dr Karl-Hermann Schlingensiepen Chief Executive Officer Antisense Pharma
Markus Kosch MD, Professor of Medicine, Associate Medical Director, Oncology, Hemophilia, Antiinfectives, Transplantation Wyeth Pharmaceuticals
Denis Mir MC, Clinical Project Manager Antisoma
Michael Lahn MD, Medical Advisor, Program Phase Oncology Eli Lilly & Company
Eric Hurden Director Clinical Operations, Oncology Biogen Idec
Herbert Sindermann PhD, Director Clinical Research Æterna Zentaris
Jean-Marc Limacher MD, MSc, Chief Medical Officer Transgene
Chantal Hondé-Pothier PhD, Coordination of Clinical Activities Manager Pierre Fabre Oncologie
Ridwaan Jhetam MD, MBA, Clinical Operations Head: Oncology, Senior Director: J&J Global Clinical Operations Johnson & Johnson
Dr Nurcan Coskun Global Clinical Operations Group Leader-Oncology F. HOFFMANN-LA ROCHE
Tim Auton PhD, Director of Scientific Operations and Project Management Protherics
Prof Dr Tanja Fehm Head of Department Gynecology, Institute for Women's Health, University Department of Gynecology and Obstetrics Comprehensive Cancer Center Tübingen
Director of Project Development        Dr Peter MacLennan   ORION Clinical Services
Dr Joerg Rennecke  Director of Operations  ORION Clinical Services